The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 09, 2021

Filed:

Jan. 13, 2017
Applicant:

University-industry Cooperation Group of Kyung Hee University, Gyeonggi-do, KR;

Inventors:

Deok Chun Yang, Gyeonggi-do, KR;

Yeon-Ju Kim, Gyeonggi-do, KR;

Singh Priyanka, Gyeonggi-do, KR;

Dong Uk Yang, Gyeonggi-do, KR;

Sung Eun Ahn, Gyeonggi-do, KR;

Mathiyalagan Ramya, Gyeonggi-do, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 36/258 (2006.01); A61K 36/24 (2006.01); A61K 9/51 (2006.01); A23L 33/105 (2016.01); A61K 31/704 (2006.01); A61K 47/69 (2017.01); A61K 47/64 (2017.01); A61P 29/00 (2006.01); A61P 35/00 (2006.01); A61K 36/25 (2006.01); B82Y 5/00 (2011.01);
U.S. Cl.
CPC ...
A61K 9/5115 (2013.01); A23L 33/105 (2016.08); A61K 9/5192 (2013.01); A61K 31/704 (2013.01); A61K 36/25 (2013.01); A61K 36/258 (2013.01); A61K 47/643 (2017.08); A61K 47/6923 (2017.08); A61K 47/6929 (2017.08); A61P 29/00 (2018.01); A61P 35/00 (2018.01); A23V 2002/00 (2013.01); B82Y 5/00 (2013.01);
Abstract

Provided are a nanocomposite including a nano-drug delivery system; and a ginseng extract or a ginsenoside isolated therefrom, and a preparation method thereof, in which the nanocomposite may be used for the prevention or treatment of cancer and inflammatory diseases. The metal nanocomposite of the present invention may be prepared in a uniform size without using an additional reducing agent or stabilizing agent in a significantly shortened time, as compared with known metal nanoparticles. Further, since the metal nanocomposite has high solubility in water and high targeting ability for cancer cells, it can be advantageously developed as drugs. Further, the metal nanocomposite exhibits high anti-cancer and anti-inflammatory activities, and thus may be usefully applied to prevention or treatment of cancer and inflammatory diseases. Furthermore, the metal nanocomposite exhibits anti-microbial activity, biofilm-degrading activity, and anti-coagulant activity, and thus may be applied to a variety of industrial fields.


Find Patent Forward Citations

Loading…